Tying payment incentives to quality measurement

Journal of Oncology Practice

Volumn 9, Issue 3, 2013, Pages 119-121

  Newcomer, Lee N ^a   Perkins, Monica R ^a   Donelan, Sheila A ^a  

^a UNITEDHEALTH GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; GRANULOCYTE COLONY STIMULATING FACTOR;

ADJUVANT THERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COLON CANCER; CONFERENCE PAPER; DRUG COST; EARLY CANCER; HEALTH INSURANCE; HOSPITAL CARE; HUMAN; LUNG CANCER; ONCOLOGY; OVERALL SURVIVAL; RADIOLOGY DEPARTMENT; TOTAL QUALITY MANAGEMENT;

HEALTH EXPENDITURES; HUMANS; MEDICAL ONCOLOGY; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 84883271851     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.000975     Document Type: Conference Paper

References (1)

1. Newcomer LN: Changing physician incentives for cancer care to reward better patient outcomes instead of use of more costly drugs. Health Aff (Millwood) 31:780-785, 2012